Cite

HARVARD Citation

    Robak, T. et al. (2010). Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Expert review of anticancer therapy. 10 (10), pp. 1529-1543. [Online]. 
  
Back to record